Terms: = Skin cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
54 results:
1. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
2. A combined opposite targeting of p110δ PI3K and rhoa abrogates skin cancer.
Tzenaki N; Xenou L; Goulielmaki E; Tsapara A; Voudouri I; Antoniou A; Valianatos G; Tzardi M; De Bree E; Berdiaki A; Makrigiannakis A; Papakonstanti EA
Commun Biol; 2024 Jan; 7(1):26. PubMed ID: 38182748
[TBL] [Abstract] [Full Text] [Related]
3. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
Zhang C; Shen C
Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
[TBL] [Abstract] [Full Text] [Related]
4. [Subcutaneous and intramuscular heterotopic calcification of the neck 42 years after radiotherapy].
Pfiszterer P; Vass G; Rovó L; Perényi Á; Kelemen G; Bach Á
Orv Hetil; 2023 Mar; 164(10):383-387. PubMed ID: 36906861
[TBL] [Abstract] [Full Text] [Related]
5. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
[TBL] [Abstract] [Full Text] [Related]
6. Monensin synergizes with chemotherapy in uveal melanoma through suppressing rhoa.
Zeng C; Long M; Lu Y
Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):35-42. PubMed ID: 36043455
[TBL] [Abstract] [Full Text] [Related]
7. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
8. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Luke JJ; Rutkowski P; Queirolo P; Del Vecchio M; Mackiewicz J; Chiarion-Sileni V; de la Cruz Merino L; Khattak MA; Schadendorf D; Long GV; Ascierto PA; Mandala M; De Galitiis F; Haydon A; Dummer R; Grob JJ; Robert C; Carlino MS; Mohr P; Poklepovic A; Sondak VK; Scolyer RA; Kirkwood JM; Chen K; Diede SJ; Ahsan S; Ibrahim N; Eggermont AMM;
Lancet; 2022 Apr; 399(10336):1718-1729. PubMed ID: 35367007
[TBL] [Abstract] [Full Text] [Related]
9. Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.
Sala M; Allain N; Moreau M; Jabouille A; Henriet E; Abou-Hammoud A; Uguen A; Di-Tommaso S; Dourthe C; Raymond AA; Dupuy JW; Gerard E; Dugot-Senant N; Rousseau B; Merlio JP; Pham-Ledart A; Vergier B; Tartare-Deckert S; Moreau V; Saltel F
Oncogene; 2022 Apr; 41(18):2571-2586. PubMed ID: 35322197
[TBL] [Abstract] [Full Text] [Related]
10. World Trade Center Health Program - United States, 2012-2020.
Azofeifa A; Martin GR; Santiago-Colón A; Reissman DB; Howard J
MMWR Surveill Summ; 2021 Sep; 70(4):1-21. PubMed ID: 34499632
[TBL] [Abstract] [Full Text] [Related]
11. Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion.
Jobe NP; Åsberg L; Andersson T
Mol Oncol; 2021 Jul; 15(7):1835-1848. PubMed ID: 33969605
[TBL] [Abstract] [Full Text] [Related]
12. A new synthetic antitumor naphthoquinone induces ROS-mediated apoptosis with activation of the JNK and p38 signaling pathways.
de Almeida PDO; Dos Santos Barbosa Jobim G; Dos Santos Ferreira CC; Rocha Bernardes L; Dias RB; Schlaepfer Sales CB; Valverde LF; Rocha CAG; Soares MBP; Bezerra DP; de Carvalho da Silva F; Cardoso MFDC; Ferreira VF; Brito LF; Pires de Sousa L; de Vasconcellos MC; Lima ES
Chem Biol Interact; 2021 Jul; 343():109444. PubMed ID: 33939975
[TBL] [Abstract] [Full Text] [Related]
13. Risk factors of local recurrence following implant-based breast reconstruction in breast cancer patients.
Fujihara M; Yamasaki R; Ito M; Shien T; Maeda R; Kin T; Ueno A; Kajiwara Y; Kawasaki K; Ichimura K; Mihara H; Kimura N; Ohtani S
BMC Womens Health; 2021 Apr; 21(1):147. PubMed ID: 33838670
[TBL] [Abstract] [Full Text] [Related]
14. Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation.
Amado-Azevedo J; van Stalborch AD; Valent ET; Nawaz K; van Bezu J; Eringa EC; Hoevenaars FPM; De Cuyper IM; Hordijk PL; van Hinsbergh VWM; van Nieuw Amerongen GP; Aman J; Margadant C
Angiogenesis; 2021 Aug; 24(3):677-693. PubMed ID: 33770321
[TBL] [Abstract] [Full Text] [Related]
15. Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.
Patrinely JR; Johnson R; Lawless AR; Bhave P; Sawyers A; Dimitrova M; Yeoh HL; Palmeri M; Ye F; Fan R; Davis EJ; Rapisuwon S; Long GV; Haydon A; Osman I; Mehnert JM; Carlino MS; Sullivan RJ; Menzies AM; Johnson DB
JAMA Oncol; 2021 May; 7(5):744-748. PubMed ID: 33764387
[TBL] [Abstract] [Full Text] [Related]
16. Exoenzyme C3 transferase lowers actin cytoskeleton dynamics, genomic stability and survival of malignant melanoma cells under UV-light stress.
Magalhaes YT; Cardella GD; Forti FL
J Photochem Photobiol B; 2020 Aug; 209():111947. PubMed ID: 32652466
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
[TBL] [Abstract] [Full Text] [Related]
18. treatment of Psoriasis With Biologics and Apremilast in Patients With a History of Malignancy: A Retrospective Chart Review.
Kahn JS; Casseres RG; Her MJ; Dumont N; Gottlieb AB; Rosmarin D
J Drugs Dermatol; 2019 Apr; 18(4):. PubMed ID: 31013012
[TBL] [Abstract] [Full Text] [Related]
19. Primary cutaneous lymphoma in Argentina: a report of a nationwide study of 416 patients.
Abeldaño A; Enz P; Maskin M; Cervini AB; Torres N; Acosta AC; Narbaitz M; Vanzulli S; Orentrajch M; Villareal MA; Garcia Pazos ML; Arias M; Zambrano Franco EA; Fontana MI; Chuit R
Int J Dermatol; 2019 Apr; 58(4):449-455. PubMed ID: 30294921
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-340 inhibits squamous cell carcinoma cell proliferation, migration and invasion by downregulating rhoa.
Wang H; Guo W; Jian Q; Xue K; Huang M; Chi S; Li C; Li C
J Dermatol Sci; 2018 Nov; 92(2):197-206. PubMed ID: 30262127
[TBL] [Abstract] [Full Text] [Related]
[Next]
